Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21%

Cardinal Health said on Monday it has agreed to buy AdaptHealth's diabetes health business and ​medi

Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, i

DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has enter

Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory,

UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price t

In the closing of the recent trading day, Cardinal Health (CAH) stood at $230.11, denoting a -1.52%

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outl

Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in f

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positio

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combina

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks E

The recommendations of Wall Street analysts are often relied on by investors when deciding whether t

CAH's Russell index removal reflects reclassification after its share rally, while specialty growth

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri

DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quart

Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt

Cardinal Health receives a Buy rating, supported by defensive business fundamentals, strong adjusted

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

B of A Securities analyst Allen Lutz maintains Cardinal Health (NYSE:CAH) with a Buy and raises t

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and lowers the pr

Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and lowers th

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and low

A sharp rotation gripped Wall Street at midday Thursday as blue-chip industrials and healthcare powe

Cardinal Health (CAH) stock falls despite an EPS beat in Q3 2026. Revenue missed estimates at $60.9B

Cardinal Health (NYSE:CAH) raises FY2026 Adj EPS guidance from $10.15-$10.35 to $10.70-$10.80 vs $10

Cardinal Health (NYSE:CAH) reported quarterly earnings of $3.17 per share which beat the analyst con

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperf

Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) prod

Cramer said, although he likes Cencora, Cardinal Health Inc. has "got them all beat." Plus: